|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer显示文摘 | Seidman AD Oshaughnessy J Misset JL | 2002 | Oncologist2002，17，6： | 1 |
| 2 | Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 ( PARP-1 ) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): results of a randomized phase II trial 显示文摘 | OSHAUGHNESSY J OSBORNE C PIPPEN J | 2009 | J Clin Oncol2009，27，6： | 1 |
| 3 | Anterior lumbar interbody fusion in comparison with transforaminal lumbar interbody fusion,implication for the restoration of foraminal height,local disc angle,lumbar lordosis,and sagittal balance显示文摘 | Hsieh PC Koski TR OShaughnessy BA | | 0，，： | 1 |
| 4 | Effects of insulin-like growth factor I on steroidogenic enzyme expression levels in mouse Leydig cells 显示文摘 | Wang GM OShaughnessy PJ Chubb C at al | 2003 | Endocrinology2003，144，： | 1 |
| 5 | Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success显示文摘 | Hiby SE Walker JJ Oshaughnessy KM | 2004 | J Exp Med2004，200，8： | 1 |
| 6 | Randomized, open-labelled, phase Ⅱ trial of orai capecitabine (Xeloda) vs a reference arm of intravenous CMF(cyclophosphamide, methotrexate and 5-fluorouracil)as first-line therapy for advanced/metastatic breast cancer显示文摘 | Oshaughnessy JA Blum J Moiseyenko V | 2001 | Ann Oncol2001，12，9： | 1 |
| 7 | Percutaneous kyphoplasty 显示文摘 | Parkinson RJ Bendok BR OShaughnessy BA | 2005 | Contemp Neurosurg2005，27，： | 1 |
| 8 | Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm 显示文摘 | Grassian V H oShaughnessy P T Adamcakova-Dodd A | 2007 | Environmental Health Perspectives2007，115，3： | 1 |
| 9 | The evolving role of capecitabine in breast canc- er显示文摘 | OShaughnessy JA | 2003 | Clin Breast Cancer2003，4，11： | 1 |
| 10 | A retrospective evaluation of the impact of dose reduction in patients treated with Xeloda (capecitabine)显示文摘 | Oshaughnessy J Blum J | 2000 | Proc Am Soc Clin Oncol2000，19，： | 1 |
| 11 | Complica tions of third-trimester amniocentesis using continuo usultrasound guidance显示文摘 | Narula K Oshaughnessy R | 2002 | Obstet Gynecol2002，99，： | 1 |
| 12 | Superior survival with capeeitabine plus docetaxel combination therapy in anthracycline-pretreated patients with ad- vanced breast cancer: Phase III trial results 显示文摘 | OShaughnessy J Miles D Vukelja S | 2002 | J Clin Oncol2002，20，12： | 1 |
| 13 | Pharmacoeconomic analysis of Xeloda (capecitabine)in combination with docetaxel for the treatment of advanced breast cancer pretreated with anthracyclines显示文摘 | Oshaughnessy JA Jones SE Vukelja SJ | 2001 | Breast Cancer Res Treat2001，69，： | 1 |
| 14 | HckSH3 domain-dependent abrogation of Nef-induced class1 MHC down-regulation显示文摘 | CHANG A H OSHAUGHNESSY M V JIRIK F R | 2001 | Eur J Immunol2001，31，8： | 1 |
| 15 | Variation in the human matrix metallopro-teinase-9 gene is associated with arterial stiffness in healthy individuals显示文摘 | Yasmin SW McEniery CM OShaughnessy KM | | 0，，： | 1 |
| 16 | Commenrary concerning demons tration of dafetyan defficac yo finve srigationalanti can cerag entsin clinicaltrials显示文摘 | Oshaughnessy JA Wittes RE Burke G | 1991 | Jclin Onclo1991，9，： | 1 |
| 17 | Progressive growth of a giant dolichoectatic vertebrobasilar artery aneurysm after complete hunterian occlusion of the posterior circulation:case report显示文摘 | OSHAUGHNESSY B A GETCH C C BENDOK B R at al | 2004 | Neurosurgery2004，55，： | 1 |
| 18 | Guide-linesfor the use of fresh-frozell plasma,cryoprecipitate an d cry-osupema-tant显示文摘 | OShaughnessy DF Atterbury C Bolton Maggs P | 2004 | Br J Haematol2004，126，1： | 1 |
| 19 | Expression of cytochrome P450 17 alpha-hydroxylase/C17-20 lyase in the fetal rat testis is reduced by maternal exposure to exogenous estrogens 显示文摘 | Majdic G Sharpe R M Oshaughnessy P J | 1996 | Endocrinology1996，137，： | 1 |
| 20 | Random- ized open label, phase II trial of oral capecitabine VSA reference am of intravenous CMF as first line therapy for advanced breast cancer 显示文摘 | Oshaughnessy J A Blum J M Moiseyenko V | 2001 | Ann Oncol2001，12，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员